-
公开(公告)号:US20100305118A1
公开(公告)日:2010-12-02
申请号:US12787915
申请日:2010-05-26
申请人: Richard F. Clark , Nwe Y. Ba-maung , Scott A. Erickson , Steve D. Fidanze , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang , Randy L. Bell
发明人: Richard F. Clark , Nwe Y. Ba-maung , Scott A. Erickson , Steve D. Fidanze , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang , Randy L. Bell
IPC分类号: A61K31/5377 , C07D401/14 , C07D417/14 , C07D413/14 , A61K31/506 , A61K31/496 , A61P35/00
CPC分类号: C07D471/04 , C07D403/14 , C07D487/04 , C07D513/04
摘要: Described herein are compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof, wherein G1, L1, R2, R3, n, p, Ar1, and Ar2 are defined in the description. Methods of making said compounds, and compositions comprising said compounds which are useful for inhibiting kinases such as IGF-1R are also disclosed.
摘要翻译: 本文描述了式(I)化合物或其药学上可接受的盐或溶剂合物,其中在说明书中定义了G1,L1,R2,R3,n,p,Ar1和Ar2。 还公开了制备所述化合物的方法,以及包含所述化合物的组合物,其可用于抑制激酶如IGF-1R。
-
公开(公告)号:US20090253723A1
公开(公告)日:2009-10-08
申请号:US12274834
申请日:2008-11-20
申请人: Nwe Y. Ba-Maung , Randy L. Bell , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Robert D. Hubbard , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang
发明人: Nwe Y. Ba-Maung , Randy L. Bell , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Robert D. Hubbard , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang
IPC分类号: A61K31/506 , C07D239/42 , A61P35/00
CPC分类号: C07D513/04
摘要: Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
摘要翻译: 公开了抑制蛋白激酶的化合物,含有化合物的组合物和使用该化合物治疗疾病的方法。
-
公开(公告)号:US08067409B2
公开(公告)日:2011-11-29
申请号:US12274834
申请日:2008-11-20
申请人: Nwe Y. Ba-Maung , Randy L. Bell , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Robert D. Hubbard , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang
发明人: Nwe Y. Ba-Maung , Randy L. Bell , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Robert D. Hubbard , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang
IPC分类号: C07D513/04 , A61K31/425
CPC分类号: C07D513/04
摘要: Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
摘要翻译: 公开了抑制蛋白激酶的化合物,含有化合物的组合物和使用该化合物治疗疾病的方法。
-
公开(公告)号:US20100305126A1
公开(公告)日:2010-12-02
申请号:US12788008
申请日:2010-05-26
申请人: Richard F. Clark , Randy L. Bell , Nwe Y. Ba-maung , Scott A. Erickson , Steve D. Fidanze , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang
发明人: Richard F. Clark , Randy L. Bell , Nwe Y. Ba-maung , Scott A. Erickson , Steve D. Fidanze , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang
IPC分类号: A61K31/5377 , C07D403/14 , C07D413/14 , A61K31/506 , A61P35/00
CPC分类号: C07D471/04 , C07D487/04 , C07D513/04
摘要: The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof, wherein G1, R2, R3, R4, R5, n, p, q, Ar1, and Ar2 are defined in the description. The present invention relates also to methods of making said compounds, and compositions comprising said compounds which are useful for inhibiting kinases such as IGF-1R.
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐或溶剂化物,其中在说明书中定义了G1,R2,R3,R4,R5,n,p,q,Ar1和Ar2。 本发明还涉及制备所述化合物的方法,以及包含所述化合物的组合物,其可用于抑制诸如IGF-1R的激酶。
-
公开(公告)号:US08536180B2
公开(公告)日:2013-09-17
申请号:US12787915
申请日:2010-05-26
申请人: Richard F. Clark , Nwe Y. Ba-maung , Scott A. Erickson , Steve D. Fidanze , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang , Randy L. Bell
发明人: Richard F. Clark , Nwe Y. Ba-maung , Scott A. Erickson , Steve D. Fidanze , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang , Randy L. Bell
IPC分类号: A61K31/497 , A61K31/535 , A61K31/505 , C07D413/14 , C07D403/14
CPC分类号: C07D471/04 , C07D403/14 , C07D487/04 , C07D513/04
摘要: Described herein are compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof, wherein G1, L1, R2, R3, n, p, Ar1, and Ar2 are defined in the description. Methods of making said compounds, and compositions comprising said compounds which are useful for inhibiting kinases such as IGF-1R are also disclosed.
摘要翻译: 本文描述了式(I)化合物或其药学上可接受的盐或溶剂合物,其中在说明书中定义了G1,L1,R2,R3,n,p,Ar1和Ar2。 还公开了制备所述化合物的方法,以及包含所述化合物的组合物,其可用于抑制激酶如IGF-1R。
-
公开(公告)号:US08354422B2
公开(公告)日:2013-01-15
申请号:US12788008
申请日:2010-05-26
申请人: Richard F. Clark , Randy L. Bell , Nwe Y. Ba-maung , Scott A. Erickson , Steve D. Fidanze , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang
发明人: Richard F. Clark , Randy L. Bell , Nwe Y. Ba-maung , Scott A. Erickson , Steve D. Fidanze , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang , Jieyi Wang
IPC分类号: C07D403/14 , C07D413/14 , A61K31/5377 , A61K31/506
CPC分类号: C07D471/04 , C07D487/04 , C07D513/04
摘要: The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof, wherein G1, R2, R3, R4, R5, n, p, q, Ar1, and Ar2 are defined in the description. The present invention relates also to methods of making said compounds, and compositions comprising said compounds which are useful for inhibiting kinases such as IGF-1R.
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐或溶剂化物,其中在说明书中定义了G1,R2,R3,R4,R5,n,p,q,Ar1和Ar2。 本发明还涉及制备所述化合物的方法,以及包含所述化合物的组合物,其可用于抑制诸如IGF-1R的激酶。
-
7.IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION 有权
标题翻译: IMIDAZOPYRIDINES作为多发性激素抑制剂的新型SCAFF公开(公告)号:US20110124632A1
公开(公告)日:2011-05-26
申请号:US12906681
申请日:2010-10-18
申请人: Nwe Y. Ba-maung , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Megumi Kawai , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang
发明人: Nwe Y. Ba-maung , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Megumi Kawai , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang
IPC分类号: A61K31/551 , C07D401/14 , A61K31/506 , C07D413/14 , A61K31/5377 , A61K31/496 , A61P35/00
CPC分类号: C07D471/04
摘要: Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
摘要翻译: 公开了抑制蛋白激酶的化合物,含有化合物的组合物和使用该化合物治疗疾病的方法。
-
8.Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition 有权
标题翻译: 咪唑并吡啶作为多靶向激酶抑制的新型支架公开(公告)号:US09051315B2
公开(公告)日:2015-06-09
申请号:US12906681
申请日:2010-10-18
申请人: Nwe Y. Ba-maung , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Megumi Kawai , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang
发明人: Nwe Y. Ba-maung , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Megumi Kawai , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang
IPC分类号: A61K31/55 , A61K31/535 , A61K31/497 , C07D223/14 , C07D413/04 , C07D239/02 , C07D471/04
CPC分类号: C07D471/04
摘要: Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
摘要翻译: 公开了抑制蛋白激酶的化合物,含有化合物的组合物和使用该化合物治疗疾病的方法。
-
公开(公告)号:US20100305112A1
公开(公告)日:2010-12-02
申请号:US12787735
申请日:2010-05-26
申请人: Gary T. Wang , Robert A. Mantei , Scott A. Erickson , Steve D. Fidanze , George S. Sheppard , Jieyi Wang , Randy L. Bell
发明人: Gary T. Wang , Robert A. Mantei , Scott A. Erickson , Steve D. Fidanze , George S. Sheppard , Jieyi Wang , Randy L. Bell
IPC分类号: A61K31/541 , A61P35/00 , C07D403/14 , A61K31/496 , A61K31/506 , A61K31/5377 , C07D413/14 , C07D417/14
CPC分类号: C07D403/12 , C07D401/14 , C07D403/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
摘要: Described herein are compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof, wherein L1, R1, R2, R3, R4, R5, and m are defined in the description. Methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as IGF-1R are also disclosed.
摘要翻译: 本文描述了式(I)的化合物或其药学上可接受的盐或溶剂合物,其中在说明书中定义了L1,R1,R2,R3,R4,R5和m。 还公开了制备所述化合物的方法和含有所述化合物的组合物,其可用于抑制激酶例如IGF-1R。
-
10.Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors 有权
标题翻译: 取代的吡唑并[3,4-d]嘧啶作为蛋白激酶抑制剂公开(公告)号:US07772231B2
公开(公告)日:2010-08-10
申请号:US11617398
申请日:2006-12-28
申请人: George S. Sheppard , Gary T. Wang , Fabio Palazzo , Randy L Bell , Robert A. Mantei , Jieyi Wang , Robert D. Hubbard , Megumi Kawai , Scott A. Erickson , Nwe BaMaung , Steve D. Fidanze
发明人: George S. Sheppard , Gary T. Wang , Fabio Palazzo , Randy L Bell , Robert A. Mantei , Jieyi Wang , Robert D. Hubbard , Megumi Kawai , Scott A. Erickson , Nwe BaMaung , Steve D. Fidanze
IPC分类号: C07D487/04 , A61K31/497 , A61K31/4985 , A61K31/519 , A61K31/5377 , C07D413/08 , A61P35/00
CPC分类号: C07D487/04
摘要: Compounds of formula (25) that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
摘要翻译: 公开了抑制蛋白激酶的式(25)化合物,含有该化合物的组合物和使用该化合物治疗疾病的方法。
-
-
-
-
-
-
-
-
-